A. Aggerholm

发表

Measurable residual disease monitoring of SPAG6, ST18, PRAME, and XAGE1A expression in peripheral blood may detect imminent relapse in childhood acute myeloid leukemia.

Linda Holmfeldt, H. Hasle, Hans B Ommen, 2021, The Journal of molecular diagnostics : JMD.

Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.

E. Kjeldsen, P. Hokland, A. T. Simonsen, 2020, Leukemia research.

Promoter hypermethylation of the retinoic acid receptor β2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFβ–MYH11 fusion transcripts

P. Guldberg, P. Hokland, A. Aggerholm, 2006, British journal of haematology.

Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders

P. Guldberg, K. Grønbæk, P. Hokland, 2000, European journal of haematology.

Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation.

M. Severinsen, M. Hansen, A. Aggerholm, 2018, Experimental hematology.

Skewed ratio between type 1 and type 2 CALR mutations in Essential Thrombocytosis patients with concomitant JAK2 V617F mutation

M. Severinsen, M. Hansen, A. Aggerholm, 2018 .

Genetic and epigenetic similarities and differences between childhood and adult AML

E. Kjeldsen, H. Hasle, P. Hokland, 2012, Pediatric blood & cancer.

Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling

P. Guldberg, P. Hokland, A. Aggerholm, 2005, British journal of haematology.

Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL

P. Guldberg, P. Hokland, A. Aggerholm, 2005, European journal of haematology.

Variant‐specific discrepancy when quantitating BCR‐ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay

H. Hasselbalch, K. Søeby, M. Andersen, 2019, European journal of haematology.

A certi ﬁ ed plasmid reference material for the standardisation of BCR – ABL1 mRNA quanti ﬁ cation by real-time quantitative PCR

D. Colomer, T. Lion, M. Jansson, 2015 .

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

J. Astermark, L. Kjeldsen, O. Linder, 2008 .

Promoter methylation as a prognostic factor in MDS 25

P. Guldberg, P. Hokland, M. Holm, 2005 .

A pharmacodynamic study of 5-azacytidine in the P39 cell line.

E. Hellström-Lindberg, Moustapha Hassan, P. Hokland, 2006, Experimental hematology.

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

S. E. Jacobsen, J. Astermark, L. Kjeldsen, 2007 .

GC bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms

L. Hansen, Morten Rasmussen, A. Zervas, 2020, GigaScience.

Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing

E. Kjeldsen, P. Hokland, J. Hindkjær, 2018, BMC Genomics.

Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients

P. Guldberg, P. Hokland, M. Holm, 2006, European journal of haematology.

DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?

P. Hokland, A. Aggerholm, 2000, Blood.

Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia.

P. Guldberg, P. Hokland, A. Aggerholm, 1999, Cancer research.

Methylation in Acute Myeloid Leukemia p 15 INK 4 B Extensive Intra-and Interindividual Heterogeneity of Updated Version

P. Guldberg, P. Hokland, A. Aggerholm, 1999 .

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis.

P. Guldberg, J. Zeuthen, A. Platz, 1998, Nucleic acids research.

In-tube DNA methylation profiling by fluorescence melting curve analysis.

P. Guldberg, A. Aggerholm, P Guldberg, 2001, Clinical chemistry.

Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia

P. Hokland, M. Østergaard, A. Aggerholm, 2008, European journal of haematology.

Diagnostic and molecular genetic challenges in male incontinentia pigmenti: a case report.

H. Gjørup, A. Aggerholm, M. Sommerlund, 2013, Acta dermato-venereologica.

Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia

E. Kjeldsen, P. Hokland, A. Aggerholm, 2013, European journal of haematology.

International external quality assurance of JAK2 V617F quantification

Niels Pallisgaard, Beatriz Bellosillo, Dina Naguib, 2018, Annals of Hematology.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

Extreme hyperleukocytosis in a pediatric T-ALL patient with a rare translocation, t(7;19)(q35;p13), and submicroscopic deletions at 4q25, 7q33 and 10q23☆

E. Kjeldsen, H. Hasle, A. Aggerholm, 2013, Leukemia research reports.

Role of mitogen‐activated protein kinases, nuclear factor‐κB, and interferon regulatory factor 3 in Toll‐like receptor 4‐mediated activation of HIV long terminal repeat

S. Paludan, L. Østergaard, A. Aggerholm, 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL‐2 expression by cytogenetic subgroups

E. Kjeldsen, R. Brøndum, H. Hasle, 2022, British journal of haematology.

Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy

E. Kjeldsen, P. Hokland, A. Aggerholm, 2018, British journal of haematology.

Persistence of DNMT3A mutations at long‐term remission in adult patients with AML

P. Guldberg, U. Jensen, P. Hokland, 2014, British journal of haematology.

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

J. Astermark, L. Kjeldsen, O. Linder, 2007, Clinical Cancer Research.

Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms.

P. Hokland, M. Hansen, A. Aggerholm, 2014, Experimental hematology.

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

J. Astermark, L. Kjeldsen, O. Linder, 2010, British journal of haematology.

The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML

E. Kjeldsen, P. Hokland, A. Aggerholm, 2009, European journal of haematology.

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation

A. Aggerholm, J. Soerensen, A. Roug, 2022, Bone Marrow Transplantation.

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.

P. Hokland, A. Aggerholm, J. Soerensen, 2020, Blood advances.

Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2.

E. Kjeldsen, H. Hasle, A. Aggerholm, 2018, Gene.

First European JAK2-V617f interlaboratory quality control study carried out by the MPN&MPNR-Euronet (COST ACTION BM0902)

Niels Pallisgaard, Hans Carl Hasselbach, A. Cassinat, 2014 .

Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry

H. Hasselbalch, A. Aggerholm, A. Roug, 2018, International journal of laboratory hematology.

Persistence of DNMT3A mutations at long‐term remission in adult patients with AML

P. Guldberg, U. Jensen, P. Hokland, 2014, British journal of haematology.

Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia

P. Hokland, A. Aggerholm, C. Nyvold, 2017, International journal of laboratory hematology.

Acute lymphoblastic leukaemia in a child with hereditary elliptocytosis

H. Russcher, C. Rehder, A. Dorgalaleh, 2022 .